Subject
Clinical Neurology,Neurology
Reference20 articles.
1. Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS;Lublin;Ann Neurol,2001
2. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment;Polman;Neurology,2008
3. The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era;McFarland;Mult Scler (Houndmills, Basingstoke, England),2005
4. Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results;Giovannoni;Mult Scler (Houndmills, Basingstoke, England),2009
5. The challenge of long-term studies in multiple sclerosis: use of pooled data, historical controls and observational studies to determine efficacy;Noseworthy,2003